Package Leaflet: Information for the User
Raxone 150 mg film-coated tablets
idebenone
This medicinal product is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the package leaflet
Raxone contains the active substance idebenone.
Idebenone is used to treat visual impairment in adults and adolescents with a rare eye disease called Leber's hereditary optic neuropathy (LHON).
Treatment with Raxone may restore the ability of cells to produce energy and allow inactive cells to function again. This may lead to some improvement in lost vision.
Do not take Raxone
Warnings and precautions
Talk to your doctor or pharmacist before taking Raxone if:
Raxone may cause your urine to turn brown-red. This color change is not dangerous (it does not mean that the treatment needs to be changed). However, the color change may indicate kidney or bladder problems.
Tests
Your doctor will check your vision before you start taking this medicine and later on during regular visits while you are taking it.
Children and adolescents
This medicine must not be used in children, as it is not known if Raxone works or is safe in patients under 12 years of age.
Using Raxone with other medicines
Some medicines may interact with Raxone. Tell your doctor if you are taking, have recently taken, or might take any other medicines, especially those used to:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and using machines
Raxone is not expected to affect your ability to drive or use machines.
Raxone contains lactose and orange yellow S (E 110)
Always take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, check with your doctor or pharmacist.
How much to take
The recommended dose is 2 tablets three times a day (a total of 6 tablets per day).
How to take this medicine
If you take more Raxone than you should
If you take more Raxone than you should, talk to your doctor as soon as possible.
If you forget to take Raxone
If you forget to take a dose, skip the missed dose. Take the next dose at the usual time.
Do not take a double dose to make up for a forgotten dose.
If you stop taking Raxone
Talk to your doctor before stopping this medicine.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Frequency not known(cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of the month shown.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Tablet core: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, povidone K25, magnesium stearate, and colloidal silicon dioxide.
Tablet coating: macrogol, poly(vinyl) alcohol, talc, titanium dioxide, and orange yellow S (E 110).
Appearance of the product and pack contents
Marketing authorisation holder and manufacturer
Santhera Pharmaceuticals (Deutschland) GmbH
Marie-Curie Strasse 8
79539 Lörrach
Germany
Phone: +49 (0) 7621 1690 200
Fax: +49 (0) 7621 1690 201
Email: office@santhera.com
Date of last revision of this leaflet
This medicine has been authorised under "exceptional circumstances".
This means that due to the rarity of this disease, it has not been possible to obtain complete information on this medicine.
The European Medicines Agency will review any new information that may become available every year and this leaflet will be updated as necessary.
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu. There are also links to other web sites about rare diseases and orphan medicines.